No Data
No Data
ARS Pharmaceuticals Price Target Announced at $18.00/Share by Raymond James
ARS Pharmaceuticals Analyst Ratings
Express News | ARS Pharmaceuticals Inc : Raymond James Initiates Coverage With Outperform Rating; Price Target $18
Raymond James Initiates ARS Pharmaceuticals(SPRY.US) With Buy Rating, Announces Target Price $18
Here's Why We're Not Too Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation
Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing
No Data
Monster madness : Guessing if they can get US approval also in the fall this will be a high double digit stock.
Trytosaveabit OP Monster madness : Howdy! So depending on where it’s trading at if/when that approval come? It very well could break up passed 13+! On another note. Yes this had some decent news for today. It just didn’t get much of a PI. The overall market was in pretty bad shape though. But it did get enough of a PI to finish making a nice small double bottom on the daily. So I will be watching very closely on Monday! See if the double bottom now continues and breaks upward! BTW sorry for the late reply! But Fridays I can’t be here after about 9:30AM est! I have a previous obligation that takes me away! I try to check in through the day if time permits. Like now. I had a few minutes before I jump in the truck to head home and decided to use the few free minutes to check in! Hope you had a good day.
Monster madness : Have a great weekend, your insight is always very appreciated
Trytosaveabit OP Monster madness : Thank you! You have a great weekend as well!